Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Pan, Qin ^a   Pan, Hongming ^a   Lou, Haizhou ^a   Xu, Yinghua ^a   Tian, Lu ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Aloin; Angiogenesis; Colorectal cancer; STAT3; Tumor growth

Indexed keywords

ALOIN; ANTINEOPLASTIC AGENT; PROTEIN BCL XL; STAT3 PROTEIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER SIZE; CANCER THERAPY; CELL CYCLE ARREST; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHINESE MEDICINE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; ONCOGENE C MYC; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 84880027971     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-69     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
2. Wang CC, Li J. An update on chemotherapy of colorectal liver metastases. World J Gastroenterol 2012, 18(1):25-33. 10.3748/wjg.v18.i1.25, 3251802, 22228967.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. 10.1016/j.cell.2011.02.013, 21376230.
4. Folkman J. Endogenous angiogenesis inhibitors. APMIS 2004, 112(7-8):496-507.
5. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008, 358(19):2039-2049. 10.1056/NEJMra0706596, 18463380.
6. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9(6):669-676. 10.1038/nm0603-669, 12778165.
7. Pang X, Wu Y, Lu B, Chen J, Wang J, Yi Z, Qu W, Liu M. Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis. Mol Cancer Ther 2011, 10(5):795-805. 10.1158/1535-7163.MCT-10-0936, 3227412, 21372225.
8. Chen SH, Murphy DA, Lassoued W, Thurston G, Feldman MD, Lee WM. Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biol Ther 2008, 7(12):1994-2003. 10.4161/cbt.7.12.6967, 2932444, 18981713.
9. Chen Z, Han ZC. STAT3: a critical transcription activator in angiogenesis. Med Res Rev 2008, 28(2):185-200. 10.1002/med.20101, 17457812.
10. Gamero AM, Young HA, Wiltrout RH. Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer?. Cancer Cell 2004, 5(2):111-112. 10.1016/S1535-6108(04)00028-5, 14998485.
11. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002, 8(4):945-954.
12. Johnston PA, Grandis JR. STAT3 signaling: anticancer strategies and challenges. Mol Interv 2011, 11(1):18-26. 10.1124/mi.11.1.4, 3063716, 21441118.
13. Chen J, Wang J, Lin L, He L, Wu Y, Zhang L, Yi Z, Chen Y, Pang X, Liu M. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Mol Cancer Ther 2012, 11(2):277-87. 10.1158/1535-7163.MCT-11-0648, 22203730.
14. Dong Y, Lu B, Zhang X, Zhang J, Lai L, Li D, Wu Y, Song Y, Luo J, Pang X, et al. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. Carcinogenesis 2010, 31(12):2097-2104. 10.1093/carcin/bgq167, 20732905.
15. Zhang X, Song Y, Wu Y, Dong Y, Lai L, Zhang J, Lu B, Dai F, He L, Liu M, et al. Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell. Int J Cancer 2011, 129(10):2502-2511. 10.1002/ijc.25909, 21207415.
16. Tabolacci C, Rossi S, Lentini A, Provenzano B, Turcano L, Facchiano F, Beninati S. Aloin enhances cisplatin antineoplastic activity in B16-F10 melanoma cells by transglutaminase-induced differentiation. Amino Acids 2013, 44(1):293-300. 10.1007/s00726-011-1166-x, 22139409.
17. Esmat AY, Tomasetto C, Rio MC. Cytotoxicity of a natural anthraquinone (Aloin) against human breast cancer cell lines with and without ErbB-2: topoisomerase IIalpha coamplification. Cancer Biol Ther 2006, 5(1):97-103.
18. Esmat AY, El-Gerzawy SM, Rafaat A. DNA ploidy and S phase fraction of breast and ovarian tumor cells treated with a natural anthracycline analog (aloin). Cancer Biol Ther 2005, 4(1):108-112. 10.4161/cbt.4.1.1445, 15662120.
19. Niciforovic A, Adzic M, Spasic SD, Radojcic MB. Antitumor effects of a natural anthracycline analog (Aloin) involve altered activity of antioxidant enzymes in HeLaS3 cells. Cancer Biol Ther 2007, 6(8):1200-1205.
20. Buenz EJ. Aloin induces apoptosis in Jurkat cells. Toxicol In Vitro 2008, 22(2):422-429. 10.1016/j.tiv.2007.10.013, 18068945.
21. Cosmetic Ingredient Review Expert Panel Final report on the safety assessment of aloe andongensis extract, aloe andongensis leaf juice,aloe arborescens leaf extract, aloe arborescens leaf juice, aloe arborescens leaf protoplasts, aloe barbadensis flower extract, aloe barbadensis leaf, aloe barbadensis leaf extract, aloe barbadensis leaf juice,aloe barbadensis leaf polysaccharides, aloe barbadensis leaf water, aloe ferox leaf extract, aloe ferox leaf juice, and aloe ferox leaf juice extract. Int J Toxicol 2007, 26(2):1-50. Cosmetic Ingredient Review Expert Panel.
22. Wamer WG, Vath P, Falvey DE. In vitro studies on the photobiological properties of aloe emodin and aloin A. Free Radic Biol Med 2003, 34(2):233-242. 10.1016/S0891-5849(02)01242-X, 12521605.
23. Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew D, Fujise K, Liu M. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Cancer Res 2009, 69(2):518-525. 10.1158/0008-5472.CAN-08-2531, 2662342, 19147565.
24. Lee HJ, Lee EO, Rhee YH, Ahn KS, Li GX, Jiang C, Lu J, Kim SH. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis. Carcinogenesis 2006, 27(12):2455-2463. 10.1093/carcin/bgl104, 16777983.
25. Fletcher GC, Brokx RD, Denny TA, Hembrough TA, Plum SM, Fogler WE, Sidor CF, Bray MR. ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action. Mol Cancer Ther 2011, 10(1):126-137.
26. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011, 146(6):873-887. 10.1016/j.cell.2011.08.039, 21925313.
27. Lee HJ, Seo NJ, Jeong SJ, Park Y, Jung DB, Koh W, Lee EO, Ahn KS, Lu J, Kim SH. Oral administration of penta-O-galloyl-beta-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition. Carcinogenesis 2011, 32(6):804-811. 10.1093/carcin/bgr015, 3106430, 21289371.
28. Yang C, Schwab JH, Schoenfeld AJ, Hornicek FJ, Wood KB, Nielsen GP, Choy E, Mankin H, Duan Z. A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol Cancer Ther 2009, 8(9):2597-2605. 10.1158/1535-7163.MCT-09-0504, 19723879.
29. Varin E, Denoyelle C, Brotin E, Meryet-Figuiere M, Giffard F, Abeilard E, Goux D, Gauduchon P, Icard P, Poulain L. Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy. Carcinogenesis 2010, 31(6):984-993. 10.1093/carcin/bgq026, 20142415.
30. Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. J Am Coll Surg 2004, 198(1):83-90. 10.1016/j.jamcollsurg.2003.08.008, 14698315.
31. Seitz SJ, Schleithoff ES, Koch A, Schuster A, Teufel A, Staib F, Stremmel W, Melino G, Krammer PH, Schilling T, et al. Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway. Int J Cancer 2010, 126(9):2049-2066.